Generation of Novel AAV Variants by Directed Evolution for Improved CFTR Delivery to Human Ciliated Airway Epithelium.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 12, p. 2067, doi. 10.1038/mt.2009.155
- By:
- Publication type:
- Article
Works matching IS 15250016 AND DT 2009 AND VI 17
Results: 300
1
2
Targeting a Dominant Negative Rho Kinase to Neurons Promotes Axonal Outgrowth and Partial Functional Recovery After Rat Rubrospinal Tract Lesion.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 12, p. 2020, doi. 10.1038/mt.2009.168
- By:
- Publication type:
- Article
3
Cationic Lipid Formulations Alter the In Vivo Tropism of AAV2/9 Vector in Lung.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 12, p. 2078, doi. 10.1038/mt.2009.173
- By:
- Publication type:
- Article
4
Generating Differentially Targeted Amyloid-β Specific Intrabodies as a Passive Vaccination Strategy for Alzheimer's Disease.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 12, p. 2031, doi. 10.1038/mt.2009.174
- By:
- Publication type:
- Article
5
Inner Limiting Membrane Barriers to AAV-mediated Retinal Transduction From the Vitreous.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 12, p. 2096, doi. 10.1038/mt.2009.181
- By:
- Publication type:
- Article
6
Molecular Evolution of Adeno-associated Virus for Enhanced Glial Gene Delivery.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 12, p. 2088, doi. 10.1038/mt.2009.184
- By:
- Publication type:
- Article
7
Preintegration HIV-1 Inhibition by a Combination Lentiviral Vector Containing a Chimeric TRIM5α Protein, a CCR5 shRNA, and a TAR Decoy.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 12, p. 2103, doi. 10.1038/mt.2009.187
- By:
- Publication type:
- Article
8
Rescue of Pyruvate Kinase Deficiency in Mice by Gene Therapy Using the Human Isoenzyme.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 12, p. 2000, doi. 10.1038/mt.2009.200
- By:
- Publication type:
- Article
9
IRES-based Vector Coexpressing FGF2 and Cyr61 Provides Synergistic and Safe Therapeutics of Lower Limb Ischemia.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 12, p. 2010, doi. 10.1038/mt.2009.211
- By:
- Publication type:
- Article
10
Expanded Anticancer Therapeutic Window of Hexon-modified Oncolytic Adenovirus.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 12, p. 2121, doi. 10.1038/mt.2009.217
- By:
- Publication type:
- Article
11
Noninvasive Imaging and Radiovirotherapy of Prostate Cancer Using an Oncolytic Measles Virus Expressing the Sodium Iodide Symporter.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 12, p. 2041, doi. 10.1038/mt.2009.218
- By:
- Publication type:
- Article
12
Abrogation of Local Cancer Recurrence After Radiofrequency Ablation by Dendritic Cell-based Hyperthermic Tumor Vaccine.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 12, p. 2049, doi. 10.1038/mt.2009.221
- By:
- Publication type:
- Article
13
Combinatorial Control of Suicide Gene Expression by Tissue-specific Promoter and microRNA Regulation for Cancer Therapy.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 12, p. 2058, doi. 10.1038/mt.2009.225
- By:
- Publication type:
- Article
14
PiggyBac Transposon-based Inducible Gene Expression In Vivo After Somatic Cell Gene Transfer.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 12, p. 2115, doi. 10.1038/mt.2009.234
- By:
- Publication type:
- Article
15
Supplying Clotting Factors From Hematopoietic Stem Cell–derived Erythroid and Megakaryocytic Lineage Cells.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 12, p. 1994, doi. 10.1038/mt.2009.238
- By:
- Publication type:
- Article
16
Molecular Therapy Moves on to a New Editor-in-Chief.
- Published in:
- 2009
- By:
- Publication type:
- Editorial
17
In This Issue.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 12, p. 1992, doi. 10.1038/mt.2009.260
- Publication type:
- Article
18
Research Highlights.
- Published in:
- 2009
- Publication type:
- Abstract
19
Identification of Protein Cofactors Necessary for Sequence-specific Plasmid DNA Nuclear Import.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 11, p. 1897, doi. 10.1038/mt.2009.127
- By:
- Publication type:
- Article
20
A Simplified Baculovirus-AAV Expression Vector System Coupled With One-step Affinity Purification Yields High-titer rAAV Stocks From Insect Cells.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 11, p. 1888, doi. 10.1038/mt.2009.128
- By:
- Publication type:
- Article
21
Mesenchymal Stem Cells Arrest Intervertebral Disc Degeneration Through Chondrocytic Differentiation and Stimulation of Endogenous Cells.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 11, p. 1959, doi. 10.1038/mt.2009.146
- By:
- Publication type:
- Article
22
Determination of the Fate and Contribution of Ex Vivo Expanded Human Bone Marrow Stem and Progenitor Cells for Bone Formation by 2.3ColGFP.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 11, p. 1967, doi. 10.1038/mt.2009.151
- By:
- Publication type:
- Article
23
Transplantation of Mesenchymal Stem Cells Overexpressing RANK-Fc or CXCR4 Prevents Bone Loss in Ovariectomized Mice.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 11, p. 1979, doi. 10.1038/mt.2009.153
- By:
- Publication type:
- Article
24
Self-inactivating Retroviral Vector-mediated Gene Transfer Induces Oncogene Activation and Immortalization of Primary Murine Bone Marrow Cells.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 11, p. 1910, doi. 10.1038/mt.2009.172
- By:
- Publication type:
- Article
25
Insertional Transformation of Hematopoietic Cells by Self-inactivating Lentiviral and Gammaretroviral Vectors.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 11, p. 1919, doi. 10.1038/mt.2009.179
- By:
- Publication type:
- Article
26
Computational Design and Application of Endogenous Promoters for Transcriptionally Targeted Gene Therapy for Rheumatoid Arthritis.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 11, p. 1877, doi. 10.1038/mt.2009.182
- By:
- Publication type:
- Article
27
Genotoxic Potential of Lineage-specific Lentivirus Vectors Carrying the β-Globin Locus Control Region.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 11, p. 1929, doi. 10.1038/mt.2009.183
- By:
- Publication type:
- Article
28
CD133 Identifies a Human Bone Marrow Stem/Progenitor Cell Sub-population With a Repertoire of Secreted Factors That Protect Against Stroke.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 11, p. 1938, doi. 10.1038/mt.2009.185
- By:
- Publication type:
- Article
29
Cell-surface Accumulation of Flock House Virus-derived Peptide Leads to Efficient Internalization via Macropinocytosis.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 11, p. 1868, doi. 10.1038/mt.2009.192
- By:
- Publication type:
- Article
30
Tight Long-term Dynamic Doxycycline Responsive Nigrostriatal GDNF Using a Single rAAV Vector.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 11, p. 1857, doi. 10.1038/mt.2009.196
- By:
- Publication type:
- Article
31
Transgene Expression Levels Determine the Immunogenicity of Transduced Hematopoietic Grafts in Partially Myeloablated Mice.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 11, p. 1904, doi. 10.1038/mt.2009.198
- By:
- Publication type:
- Article
32
Drug Nanocarriers Labeled With Near-infrared-emitting Quantum Dots (Quantoplexes): Imaging Fast Dynamics of Distribution in Living Animals.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 11, p. 1849, doi. 10.1038/mt.2009.201
- By:
- Publication type:
- Article
33
Aldehyde Dehydrogenase Activity Identifies a Population of Human Skeletal Muscle Cells With High Myogenic Capacities.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 11, p. 1948, doi. 10.1038/mt.2009.204
- By:
- Publication type:
- Article
34
Accepting Risk in Clinical Research: Is the Gene Therapy Field Becoming Too Risk-averse?
- Published in:
- Molecular Therapy, 2009, v. 17, n. 11, p. 1842, doi. 10.1038/mt.2009.223
- By:
- Publication type:
- Article
35
Tomorrow, Interrupted?: Risk, Ethics, and Medical Advance in Gene Transfer.
- Published in:
- 2009
- By:
- Publication type:
- Opinion
36
Autophagy Links Pattern Recognition Receptors to Tumor Cell Apoptosis.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 11, p. 1839, doi. 10.1038/mt.2009.241
- By:
- Publication type:
- Article
37
Risk in Clinical Research: Size Matters!
- Published in:
- 2009
- By:
- Publication type:
- Editorial
38
In This Issue.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 11, p. 1836, doi. 10.1038/mt.2009.243
- Publication type:
- Article
39
Research Highlights.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 11, p. 1837, doi. 10.1038/mt.2009.244
- Publication type:
- Article
40
Immunotherapy for Osteosarcoma: Genetic Modification of T cells Overcomes Low Levels of Tumor Antigen Expression.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 10, p. 1779, doi. 10.1038/mt.2009.133
- By:
- Publication type:
- Article
41
Effect of VEGF on the Regenerative Capacity of Muscle Stem Cells in Dystrophic Skeletal Muscle.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 10, p. 1788, doi. 10.1038/mt.2009.136
- By:
- Publication type:
- Article
42
Corrigendum to “Gene Therapy for Diabetes: Metabolic Effects of Helper-dependent Adenoviral Exendin 4 Expression in a Diet-induced Obesity Mouse Model”.
- Published in:
- 2009
- Publication type:
- Correction Notice
43
Amelioration of Psoriasis by Anti-TNF-α RNAi in the Xenograft Transplantation Model.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 10, p. 1743, doi. 10.1038/mt.2009.141
- By:
- Publication type:
- Article
44
Biosafety in Ex Vivo Gene Therapy and Conditional Ablation of Lentivirally Transduced Hepatocytes in Nonhuman Primates.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 10, p. 1754, doi. 10.1038/mt.2009.143
- By:
- Publication type:
- Article
45
Conditions for Tumor-free and Dopamine Neuron–enriched Grafts After Transplanting Human ES Cell–derived Neural Precursor Cells.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 10, p. 1761, doi. 10.1038/mt.2009.148
- By:
- Publication type:
- Article
46
Influence of Coagulation Factor X on In Vitro and In Vivo Gene Delivery by Adenovirus (Ad) 5, Ad35, and Chimeric Ad5/Ad35 Vectors.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 10, p. 1683, doi. 10.1038/mt.2009.152
- By:
- Publication type:
- Article
47
Vesicular Stomatitis Virus as a Novel Cancer Vaccine Vector to Prime Antitumor Immunity Amenable to Rapid Boosting With Adenovirus.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 10, p. 1814, doi. 10.1038/mt.2009.154
- By:
- Publication type:
- Article
48
Pre-existing Immunity and Passive Immunity to Adenovirus 5 Prevents Toxicity Caused by an Oncolytic Adenovirus Vector in the Syrian Hamster Model.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 10, p. 1724, doi. 10.1038/mt.2009.156
- By:
- Publication type:
- Article
49
Allogeneic Mesenchymal Stem Cells for Treatment of Experimental Autoimmune Encephalomyelitis.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 10, p. 1799, doi. 10.1038/mt.2009.157
- By:
- Publication type:
- Article
50
Impact of the Underlying Mutation and the Route of Vector Administration on Immune Responses to Factor IX in Gene Therapy for Hemophilia B.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 10, p. 1733, doi. 10.1038/mt.2009.159
- By:
- Publication type:
- Article